Vorinostat-Polymer Conjugate Nanoparticles for Acid-Responsive Delivery and Passive Tumor Targeting

被引:26
作者
Denis, Iza [1 ,2 ,3 ]
el Bahhaj, Fatima [5 ]
Collette, Floraine [4 ]
Delatouche, Regis [5 ]
Gueugnon, Fabien [1 ,2 ,3 ]
Pouliquen, Daniel [1 ,2 ,3 ]
Pichavant, Loic [4 ]
Heroguez, Valerie [4 ]
Gregoire, Marc [1 ,2 ,3 ]
Bertrand, Philippe [5 ,6 ]
Blanquart, Christophe [1 ,2 ,3 ,6 ]
机构
[1] INSERM, UMR 892, F-44000 Nantes, France
[2] CNRS, UMR 6299, F-44000 Nantes, France
[3] Univ Nantes, F-44007 Nantes 1, France
[4] CNRS, Lab Chim Polymeres Organ, UMR 5629, F-33607 Pessac, France
[5] CNRS, Inst Chim Milieux & Mat Poitiers, UMR 7582, F-86000 Poitiers, France
[6] Reseau Epigenet Canc Pole Grand Ouest, Grand Ouest, France
关键词
HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; IN-VIVO; MESOTHELIOMA; GROWTH; CELLS; SERUM; NANOCARRIERS; METABOLITES; APOPTOSIS;
D O I
10.1021/bm501338r
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vivo histone deacetylase (HDAC) inhibition by vorinostat under clinically acceptable dosing is limited by its poor pharmacokinetics properties. A new type of nontoxic pH-responsive delivery system has been synthesized by ring-opening metathesis polymerization, allowing for the selective distribution of vorinostat in mesothelioma tumors in vivo and subsequent histone reacetylation. The delivery system is synthesized by generic click chemistry, possesses native stealth properties for passive tumor targeting, and does not need additional chemistry for cellular internalization. Although vorinostat alone at 50 mg/kg in mice showed no effect, our new delivery system with 2 mg/kg vorinostat promoted histone reacetylation in tumors without side effects, demonstrating that our strategy improves the activity of this HDAC inihibitor in vivo.
引用
收藏
页码:4534 / 4543
页数:10
相关论文
共 25 条
[1]   Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression [J].
Barbone, Dario ;
Cheung, Priscilla ;
Battula, Sailaja ;
Busacca, Sara ;
Gray, Steven G. ;
Longley, Daniel B. ;
Bueno, Raphael ;
Sugarbaker, David J. ;
Fennell, Dean A. ;
Broaddus, V. Courtney .
PLOS ONE, 2012, 7 (12)
[2]   Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds [J].
Blanquart, C. ;
Francois, M. ;
Charrier, C. ;
Bertrand, P. ;
Gregoire, M. .
CURRENT CANCER DRUG TARGETS, 2011, 11 (08) :919-928
[3]  
Butler LM, 2000, CANCER RES, V60, P5165
[4]   Easy and effective method to produce functionalized particles for cellular uptake [J].
Collette, Floraine ;
Delatouche, Regis ;
Blanquart, Christophe ;
Gueugnon, Fabien ;
Gregoire, Marc ;
Bertrand, Philippe ;
Heroguez, Valerie .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 2013, 51 (01) :176-189
[5]   Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities [J].
Dedes, Konstantin J. ;
Dedes, Ioannis ;
Imesch, Patrick ;
von Bueren, Andre O. ;
Fink, Daniel ;
Fedier, Andre .
ANTI-CANCER DRUGS, 2009, 20 (05) :321-333
[6]   Design of pH responsive clickable prodrugs applied to histone deacetylase inhibitors: A new strategy for anticancer therapy [J].
Delatouche, Regis ;
Denis, Iza ;
Grinda, Marion ;
El Bahhaj, Fatima ;
Baucher, Estelle ;
Collette, Floraine ;
Heroguez, Valerie ;
Gregoire, Marc ;
Blanquart, Christophe ;
Bertrand, Philippe .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) :862-872
[7]   Stability studies of vorinostat and its two metabolites in human plasma, serum and urine [J].
Du, Lihong ;
Musson, Donald G. ;
Wang, Amy Qiu .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 42 (05) :556-564
[8]   Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma [J].
Duvic, Madeleine ;
Vu, Jenny .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (07) :1111-1120
[9]   Delivery of epidrugs [J].
el Bahhaj, Fatima ;
Dekker, Frank J. ;
Martinet, Nadine ;
Bertrand, Philippe .
DRUG DISCOVERY TODAY, 2014, 19 (09) :1337-1352
[10]   Hydroxamates: Relationships between Structure and Plasma Stability [J].
Flipo, Marion ;
Charton, Julie ;
Hocine, Akila ;
Dassonneville, Sandrine ;
Deprez, Benoit ;
Deprez-Poulain, Rebecca .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) :6790-6802